Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

246 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Serum YKL-40: a new potential marker of prognosis and location of metastases of patients with recurrent breast cancer.
Johansen JS, Cintin C, Jørgensen M, Kamby C, Price PA. Johansen JS, et al. Eur J Cancer. 1995;31A(9):1437-42. doi: 10.1016/0959-8049(95)00196-p. Eur J Cancer. 1995. PMID: 7577068
Cancer risk by combined levels of YKL-40 and C-reactive protein in the general population.
Allin KH, Bojesen SE, Johansen JS, Nordestgaard BG. Allin KH, et al. Among authors: johansen js. Br J Cancer. 2012 Jan 3;106(1):199-205. doi: 10.1038/bjc.2011.501. Epub 2011 Nov 17. Br J Cancer. 2012. PMID: 22095223 Free PMC article.
Serum-free gamma carboxyglutamic acid (free Gla) is a poor biochemical marker of bone resorption in early postmenopausal women.
Johansen JS, Delmas PD, Riis BJ, Gineyts E, Christiansen C. Johansen JS, et al. Bone. 1991;12(4):257-60. doi: 10.1016/8756-3282(91)90072-q. Bone. 1991. PMID: 1793675 Clinical Trial.
Bone turnover in spinal osteoporosis.
Pødenphant J, Johansen JS, Thomsen K, Riis BJ, Leth A, Christiansen C. Pødenphant J, et al. Among authors: johansen js. J Bone Miner Res. 1987 Dec;2(6):497-503. doi: 10.1002/jbmr.5650020606. J Bone Miner Res. 1987. PMID: 3502682
Bone metabolism and bone status in osteoporotic patients.
Hartwell D, Riis BJ, Christiansen C, Thomsen K, Johansen JS, Rødbro P. Hartwell D, et al. Among authors: johansen js. Acta Med Scand. 1987;222(5):453-8. doi: 10.1111/j.0954-6820.1987.tb10964.x. Acta Med Scand. 1987. PMID: 3425398
Serum bone Gla-protein as a marker of bone growth in children and adolescents: correlation with age, height, serum insulin-like growth factor I, and serum testosterone.
Johansen JS, Giwercman A, Hartwell D, Nielsen CT, Price PA, Christiansen C, Skakkebaek NE. Johansen JS, et al. J Clin Endocrinol Metab. 1988 Aug;67(2):273-8. doi: 10.1210/jcem-67-2-273. J Clin Endocrinol Metab. 1988. PMID: 3260598
Serum bone Gla protein: a potential marker of growth hormone (GH) deficiency and the response to GH therapy.
Johansen JS, Jensen SB, Riis BJ, Rasmussen L, Zachmann M, Christiansen C. Johansen JS, et al. J Clin Endocrinol Metab. 1990 Jul;71(1):122-6. doi: 10.1210/jcem-71-1-122. J Clin Endocrinol Metab. 1990. PMID: 2370291
Serum bone Gla protein (BGP) during treatment of hyperthyroidism and hypothyroidism. A longitudinal study.
Faber J, Perrild H, Johansen JS. Faber J, et al. Among authors: johansen js. Horm Metab Res. 1991 Mar;23(3):135-8. doi: 10.1055/s-2007-1003633. Horm Metab Res. 1991. PMID: 1864560
Serum bone gamma-carboxyglutamic acid protein in a longitudinal study of infants: lower values in formula-fed infants.
Michaelsen KF, Johansen JS, Samuelson G, Price PA, Christiansen C. Michaelsen KF, et al. Among authors: johansen js. Pediatr Res. 1992 Apr;31(4 Pt 1):401-5. doi: 10.1203/00006450-199204000-00019. Pediatr Res. 1992. PMID: 1570207
Is it possible to prevent bone loss in young women treated with luteinizing hormone-releasing hormone agonists?
Riis BJ, Christiansen C, Johansen JS, Jacobson J. Riis BJ, et al. Among authors: johansen js. J Clin Endocrinol Metab. 1990 Apr;70(4):920-4. doi: 10.1210/jcem-70-4-920. J Clin Endocrinol Metab. 1990. PMID: 2138631
246 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback